Immunovant (IMVT)
(Delayed Data from NSDQ)
$28.08 USD
-0.14 (-0.50%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $28.77 +0.69 (2.46%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/27/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.36 |
Last EPS Surprise | 18.18% |
ABR | 1.06 |
Earnings ESP
|
-8.80% |
---|---|
Current Year | -1.78 |
Next Year | -1.82 |
EPS (TTM) | -1.74 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.46 | -1.78 | -1.82 |
# of Estimates | 10 | 7 | 9 | 10 |
Most Recent Consensus | -0.46 | -0.53 | -1.71 | -1.78 |
High Estimate | -0.35 | -0.39 | -1.70 | -0.83 |
Low Estimate | -0.49 | -0.53 | -1.85 | -2.22 |
Year ago EPS | -0.46 | -0.47 | -1.71 | -1.78 |
Year over Year Growth Est. | 6.52% | 2.13% | -4.09% | -2.07% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.46 | -1.78 | -1.82 |
7 Days Ago | -0.43 | -0.46 | -1.78 | -1.84 |
30 Days Ago | -0.43 | -0.47 | -1.79 | -1.84 |
60 Days Ago | -0.45 | -0.49 | -1.82 | -1.86 |
90 Days Ago | -0.47 | -0.55 | -1.89 | -1.92 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.47 | -0.44 | -1.78 | -1.86 |
Zacks Consensus Estimate | -0.43 | -0.46 | -1.78 | -1.82 |
Earnings ESP | -8.80% | 4.94% | 0.00% | -2.25% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.36 | -0.45 | -0.47 | -0.46 | NA |
Estimate | -0.44 | -0.46 | -0.44 | -0.48 | NA |
Difference | 0.08 | 0.01 | -0.03 | 0.02 | 0.02 |
Surprise | 18.18% | 2.17% | -6.82% | 4.17% | 4.43% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more